248 related articles for article (PubMed ID: 2991321)
1. Molecular forms of glucagon-like peptide-1 in human pancreas and glucagonomas.
Uttenthal LO; Ghiglione M; George SK; Bishop AE; Polak JM; Bloom SR
J Clin Endocrinol Metab; 1985 Sep; 61(3):472-9. PubMed ID: 2991321
[TBL] [Abstract][Full Text] [Related]
2. Molecular forms of glucagon-like peptides in man.
George SK; Uttenthal LO; Ghiglione M; Bloom SR
FEBS Lett; 1985 Nov; 192(2):275-8. PubMed ID: 3840748
[TBL] [Abstract][Full Text] [Related]
3. Developmental patterns of glucagon-like peptide-1-(7-36) amide and peptide-YY in rat pancreas and gut.
Kreymann B; Ghatei MA; Domin J; Kanse S; Bloom SR
Endocrinology; 1991 Aug; 129(2):1001-5. PubMed ID: 1677327
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-1 (GLP-1) molecular forms in human pancreatic endocrine tumors resemble those in intestine rather than pancreas.
Tateishi K; Shima K; Funakoshi A; Yasunami Y; Iwamoto N; Matsuoka Y
Diabetes Res Clin Pract; 1994 Aug; 25(1):43-9. PubMed ID: 7835211
[TBL] [Abstract][Full Text] [Related]
5. Differences in molecular heterogeneity of glucagon-like immunoreactivity in plasma and liver metastases of a patient with alpha-cell tumor.
Kohnert KD; Kändler C; Woltanski KP; Ziegler M
Exp Clin Endocrinol; 1985 Feb; 85(1):89-94. PubMed ID: 2985414
[TBL] [Abstract][Full Text] [Related]
6. Proglucagon processing similar to normal islets in pancreatic alpha-like cell line derived from transgenic mouse tumor.
Powers AC; Efrat S; Mojsov S; Spector D; Habener JF; Hanahan D
Diabetes; 1990 Apr; 39(4):406-14. PubMed ID: 2156740
[TBL] [Abstract][Full Text] [Related]
7. Peptide histidine-methionine immunoreactivity in plasma and tissue from patients with vasoactive intestinal peptide-secreting tumors and watery diarrhea syndrome.
Yiangou Y; Williams SJ; Bishop AE; Polak JM; Bloom SR
J Clin Endocrinol Metab; 1987 Jan; 64(1):131-9. PubMed ID: 3023426
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas.
Orskov C; Holst JJ; Knuhtsen S; Baldissera FG; Poulsen SS; Nielsen OV
Endocrinology; 1986 Oct; 119(4):1467-75. PubMed ID: 3530719
[TBL] [Abstract][Full Text] [Related]
9. Molecular heterogeneity of glucagon in normal subjects and in patients with glucagon-producing tumours.
Holst JJ
Diabetologia; 1983 May; 24(5):359-65. PubMed ID: 6307793
[TBL] [Abstract][Full Text] [Related]
10. A large molecular form of glucagon-like peptide-1 (GLP-1) immunoreactivity is co-released with glucagon from pancreas by arginine in normal subjects.
Hirota M; Shimizu I; Ohboshi C; Nishino T; Shima K
Clin Chim Acta; 1987 Aug; 167(3):293-302. PubMed ID: 3304721
[TBL] [Abstract][Full Text] [Related]
11. Localization of glucagon-like peptide (GLP) immunoreactants in human gut and pancreas using light and electron microscopic immunocytochemistry.
Varndell IM; Bishop AE; Sikri KL; Uttenthal LO; Bloom SR; Polak JM
J Histochem Cytochem; 1985 Oct; 33(10):1080-6. PubMed ID: 3900195
[TBL] [Abstract][Full Text] [Related]
12. Distribution and molecular forms of glucagon-like peptide in the dog.
Suda K; Takahashi H; Fukase N; Manaka H; Tominaga M; Sasaki H
Life Sci; 1989; 45(19):1793-8. PubMed ID: 2593768
[TBL] [Abstract][Full Text] [Related]
13. Release of glucagon-like peptide 1 immunoreactivity from the perfused rat pancreas.
Shima K; Hirota M; Ohboshi C; Sato M; Nishino T
Acta Endocrinol (Copenh); 1987 Apr; 114(4):531-6. PubMed ID: 3577586
[TBL] [Abstract][Full Text] [Related]
14. Radio-immunoassays for glucagon-like peptides 1 and 2 (GLP-1 and GLP-2).
Orskov C; Holst JJ
Scand J Clin Lab Invest; 1987 Apr; 47(2):165-74. PubMed ID: 3576119
[TBL] [Abstract][Full Text] [Related]
15. Identification of amidated forms of GLP-1 in rat tissues using a highly sensitive radioimmunoassay.
van Delft J; Uttenthal LO; Hermida OG; Fontela T; Ghiglione M
Regul Pept; 1997 Jun; 70(2-3):191-8. PubMed ID: 9272633
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic and intestinal processing of proglucagon in man.
Orskov C; Holst JJ; Poulsen SS; Kirkegaard P
Diabetologia; 1987 Nov; 30(11):874-81. PubMed ID: 3446554
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of insulin, glucagon, and two glucagon-like peptides with insulin-releasing activity from the pancreas of the toad, Bufo marinus.
Conlon JM; Abdel-Wahab YH; O'Harte FP; Nielsen PF; Whittaker J
Endocrinology; 1998 Aug; 139(8):3442-8. PubMed ID: 9681494
[TBL] [Abstract][Full Text] [Related]
18. Internalization of glucagon-like peptide-1(7-36)amide in rat insulinoma cells.
Göke R; Richter G; Göke B; Trautmann M; Arnold R
Res Exp Med (Berl); 1989; 189(4):257-64. PubMed ID: 2554438
[TBL] [Abstract][Full Text] [Related]
19. Molecular forms of glucagon-like immunoreactivity in porcine intestine and pancreas.
Ghatei MA; Uttenthal LO; Bryant MG; Christofides ND; Moody AJ; Bloom SR
Endocrinology; 1983 Mar; 112(3):917-23. PubMed ID: 6822217
[TBL] [Abstract][Full Text] [Related]
20. Both amidated and nonamidated forms of glucagon-like peptide I are synthesized in the rat intestine and the pancreas.
Mojsov S; Kopczynski MG; Habener JF
J Biol Chem; 1990 May; 265(14):8001-8. PubMed ID: 1692320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
